[28H-pm] Pharmacotherapies (Clinical)-2

Mon. Mar 28, 2022 3:30 PM - 4:30 PM [Room H] Conference Room 221 (Bldg. 2: 2F)

Chair: Toshiyasu Sasaoka

+Add all to schedule

3:30 PM - 3:42 PM

[28H-pm11S] Effects of SGLT2 inhibitors on Muscle Mass in Type 2 Diabetes Mellitus: meta-analysis

○Haruna Komatsu¹, Yosuke Suzuki¹, Chisato Yoshijima¹, Ayako Oda¹, Keiko Ohno¹ (1. Meiji Pharmaceutical University)

3:42 PM - 3:54 PM

[28H-pm12S] Evaluation of the safety of triptans in pregnant women with migraine: meta-analysis

○Mami Yuasa¹, Yosuke Suzuki¹, Chisato Yoshijima¹, Ayako Oda¹, Keiko Ohno¹ (1. Meiji Pharmaceutical University)

3:54 PM - 4:06 PM

[28H-pm13S] Use of Japanese big data and a data mining analysis to investigate risk factors for linezolid-induced thrombocytopenia

○Yuki Inoue¹, Yoh Takekuma², Takayuki Miyai¹, Hitoshi Kashiwagi³, Yuki Sato³, Mitsuru Sugawara^2,3, Shungo Imai³ (1. Grad. Sch. Life Sci., Hokkaido Univ., 2. Dept. pharm., Hokkaido Univ Hosp., 3. Grad. Sch. Pharm. Sci., Hokkaido Univ.)

4:06 PM - 4:18 PM

[28H-pm14S] Quantitative prediction of the effect of oral steroids on HbA1c

○Shuhei Higuchi¹, Hirofumi Tamaki^1,2, Yoko Ino^1,2, Arihiro Osanai^1,2, Shuji Yamashita^2,3, Yoshihiro Noguchi^2,4, Kazuhiro Iguchi^1,2, Hitomi Teramachi^2,4 (1. Laboratory of Community Pharmacy, Gifu Pharmaceutical Univ., 2. Gifu Pharmaceutical University Pharmacy, 3. Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical Univ., 4. Laboratory of Clinical Pharmacy, Gifu Pharmaceutical Univ.)

4:18 PM - 4:30 PM

[28H-pm15] Safety of Remdesivir in patients with moderate COVID-19

○Haruki Takasaki¹, Norihiro Moriwaki¹, Kohei Noda¹, Mai Shioiri¹, Tadahiro Ikeuchi¹, Susumu Kaneshige¹, Hidetoshi Kamimura^1,2 (1. Department of Pharmacy, Fukuoka University Hospital, 2. Faculty of Pharmaceutical Sciences, Fukuoka University)

Session information